In-vivo imaging of a2 adrenoceptors in Parkinson's disease with 11C-yohimbine

被引：0
|
作者：
Nahimi, A. [1 ,2 ]
Kinnerup, M. B. [1 ,2 ]
Ostergaard, K. [3 ]
Winterdahl, M. [1 ,2 ]
Fedorova, T. [1 ,2 ]
Jakobsen, S. [1 ,2 ]
Schaldemose, J. [1 ,2 ]
Sommerauer, M. [3 ]
Borghammer, P. [1 ,2 ]
Gjedde, A. [4 ]
机构：
[1] Aarhus Univ Hosp, Dept Nucl Med, Aarhus C, Denmark
[2] Aarhus Univ Hosp, PET Ctr, Aarhus C, Denmark
[3] Aarhus Univ Hosp, Dept Neurol, Aarhus C, Denmark
[4] Univ Copenhagen, Dept Neurosci & Pharmacol, Copenhagen, Denmark
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2017年 / 24卷
基金：
瑞士国家科学基金会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
PR2114
引用
收藏
页码：594 / 595
页数：2
相关论文
共 50 条
  • [31] Test-retest reliability of 11C-ORM-13070 in PET imaging of α2C-adrenoceptors in vivo in the human brain
    Lehto, Jussi
    Virta, Jere R.
    Oikonen, Vesa
    Roivainen, Anne
    Luoto, Pauliina
    Arponen, Eveliina
    Helin, Semi
    Hietamaki, Johanna
    Holopainen, Aila
    Kailajarvi, Marita
    Peltonen, Juha M.
    Rouru, Juha
    Sallinen, Jukka
    Virtanen, Kirsi
    Volanen, Iina
    Scheinin, Mika
    Rinne, Juha O.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (01) : 120 - 127
  • [32] In-vivo retinal imaging of amyloid deposits as biomarker for Alzheimer's disease
    Mujat, Mircea
    Patel, Ankit
    Grimble, John
    Iftimia, Nicusor
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (09)
  • [33] [11C] PIB binding in Parkinson's disease
    Maetzler, W.
    Reimold, M.
    Liepelt, I.
    Solbach, C.
    Gasser, T.
    Berg, D.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (03) : XXI - XXI
  • [34] Imaging acetylcholinesterase density in peripheral organs in Parkinson's disease with 11C-donepezil PET
    Gjerloff, Trine
    Fedorova, Tatyana
    Knudsen, Karoline
    Munk, Ole L.
    Nahimi, Adjmal
    Jacobsen, Steen
    Danielsen, Erik H.
    Terkelsen, Astrid J.
    Hansen, John
    Pavese, Nicola
    Brooks, David J.
    Borghammer, Per
    BRAIN, 2015, 138 : 653 - 663
  • [35] Development and Screening of Contrast Agents for In Vivo Imaging of Parkinson's Disease
    Neal, Krista L.
    Shakerdge, Naomi B.
    Hou, Steven S.
    Klunk, William E.
    Mathis, Chester A.
    Nesterov, Evgueni E.
    Swager, Timothy M.
    McLean, Pamela J.
    Bacskai, Brian J.
    MOLECULAR IMAGING AND BIOLOGY, 2013, 15 (05) : 585 - 595
  • [36] Development and Screening of Contrast Agents for In Vivo Imaging of Parkinson’s Disease
    Krista L. Neal
    Naomi B. Shakerdge
    Steven S. Hou
    William E. Klunk
    Chester A. Mathis
    Evgueni E. Nesterov
    Timothy M. Swager
    Pamela J. McLean
    Brian J. Bacskai
    Molecular Imaging and Biology, 2013, 15 : 585 - 595
  • [37] In vivo imaging in cell and gene therapy for Parkinson's disease.
    Muramatsu, Shin-ichi
    JOURNAL OF GENE MEDICINE, 2014, 16 (7-8): : 214 - 214
  • [38] In vivo imaging of presynaptic terminal loss in early Parkinson's disease
    Delva, A.
    Van Weehaeghe, D.
    Koole, M.
    Van Laere, K.
    Vandenberghe, W.
    MOVEMENT DISORDERS, 2020, 35 : S392 - S393
  • [39] Serotonergic Terminals Are Differentially Affected in Parkinson's Disease: An In Vivo 11C-DASB PET Study
    Politis, Marios
    Wu, Kit
    Loane, Clare
    Kiferle, Lorenzo
    Molloy, Sophie
    Brooks, David J.
    Piccini, Paola
    NEUROLOGY, 2010, 74 (09) : A590 - A590
  • [40] [11C]PHNO and [11C]racloride PET imaging of dopamine receptors in drug-naive Parkinson's disease
    Boileau, Isabelle
    Guttman, Mark
    Houle, Sylvain
    Rusjan, Pablo
    Wilson, Alan A.
    Kapur, Shitij
    Kish, Stephen J.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 228S - 228S
12345